Guiyang Xintian Pharmaceutical Co.,Ltd.
SZSE:002873.SZ
11.54 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| 52.323 | 80.871 | 116.102 | 100.605 | 74.103 | 70.866 | 70.395 | 66.117 | 57.069 | 42.01 | 33.124 | 15.095 | 26.393 |
| Depreciation & Amortization
| 37.375 | 24.723 | 25.449 | 22.806 | 19.088 | 16.005 | 13.561 | 11.918 | 12.393 | 7.818 | 6.352 | 6.066 | 6.023 |
| Deferred Income Tax
| 0 | 0 | 5.442 | 1.339 | -4.252 | -3.952 | -0.413 | 0.263 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -10.897 | -44.54 | -83.295 | -21.518 | 60.903 | -64.151 | -37.941 | -16.419 | -21.006 | -25.716 | -15.607 | -20.685 | -20.899 |
| Accounts Receivables
| -38.028 | 6.998 | -20.177 | -8.448 | 37.469 | -52.927 | -45.145 | -9.176 | -25.645 | -6.889 | 16.07 | 0 | 0 |
| Inventory
| 35.801 | -1.198 | -66.754 | -40.349 | 7.685 | -12.127 | -16.006 | -23.268 | 0.586 | -10.25 | 4.881 | 19.194 | -6.958 |
| Accounts Payables
| 0 | -52.081 | -1.806 | 25.94 | 20.001 | 4.855 | 23.623 | 15.762 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -8.67 | 1.741 | 5.442 | 1.339 | -4.252 | -3.952 | -21.935 | 6.85 | -21.592 | -15.466 | -20.488 | -39.88 | -13.941 |
| Other Non Cash Items
| 9.329 | 16.729 | 2.155 | 22.407 | 21.674 | 11.009 | 1.577 | 0.444 | 12.888 | 16.618 | 13.436 | 13.403 | 9.891 |
| Operating Cash Flow
| 88.13 | 77.782 | 75.818 | 124.3 | 175.768 | 33.728 | 47.593 | 62.06 | 61.344 | 40.731 | 37.304 | 13.879 | 21.407 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -61.453 | -101.702 | -129.203 | -105.692 | -68.148 | -156.075 | -40.541 | -105.212 | -13.771 | -33.655 | -39.379 | -35.851 | -54.471 |
| Acquisitions Net
| 0 | 0 | 0.03 | 0.082 | 69.5 | 165.42 | 0 | 106.349 | 0 | 2.922 | 0 | 0.123 | 0 |
| Purchases Of Investments
| 0 | -0.001 | -85 | -665 | -544.87 | -163.7 | -638 | -220 | 0 | 0 | 0 | 0.26 | 0 |
| Sales Maturities Of Investments
| 0.001 | 0.003 | 135 | 553 | 285 | 307.086 | 653.944 | 75.809 | 0 | 0.06 | 0.06 | 0.055 | 0.055 |
| Other Investing Activites
| 15.08 | 5.003 | 0 | 0 | -68.148 | -156.075 | -2.197 | -105.212 | 0 | 2.922 | 1.11 | 0.5 | 14.984 |
| Investing Cash Flow
| -46.372 | -96.697 | -79.173 | -217.61 | -326.667 | -3.344 | -26.795 | -248.266 | -13.771 | -30.673 | -38.209 | -34.913 | -39.432 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| 102.71 | 102 | 69 | -145.633 | 331.305 | 47.127 | 68 | 0 | -7.39 | -16.795 | 67.8 | 40.6 | 13.5 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12.087 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -2.989 | -3.101 | -15.021 | -2.699 | -16.921 | -15.975 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -35.06 | -42.527 | -19.887 | -14.015 | -11.494 | -5.776 | -21.871 | -19.731 | -19.152 | -18.889 | -15.313 | -40.218 | -7.555 |
| Other Financing Activities
| -129.48 | -0 | -14.468 | 26.689 | -3.047 | -29.327 | 1.791 | 229.94 | -1.427 | -2.614 | -3.232 | -3.793 | -4.168 |
| Financing Cash Flow
| -61.83 | 56.483 | 31.544 | -164.3 | 299.331 | 12.025 | 31.945 | 210.209 | -27.969 | -38.298 | 49.256 | -3.412 | 1.777 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | -0 | 0 | 0 | -0 | 0 | 0 | 0 | -0 | 0 | 4.055 | 13.869 |
| Net Change In Cash
| -20.073 | 37.569 | 28.189 | -257.609 | 148.431 | 42.409 | 52.743 | 24.003 | 19.604 | -28.24 | 48.351 | -20.391 | -2.379 |
| Cash At End Of Period
| 118.164 | 138.237 | 100.668 | 72.478 | 330.087 | 181.656 | 139.247 | 86.504 | 62.502 | 42.898 | 71.138 | 22.787 | 43.178 |